Literature DB >> 27400441

Reported work-related injuries and illnesses among Hispanic workers: Results from an emergency department surveillance system follow-back survey.

Theresa R Tonozzi1, Suzanne M Marsh1, Audrey A Reichard1, Ruchi Bhandari1.   

Abstract

BACKGROUND: Research suggests Hispanic workers underreport injuries/illnesses to their employer.
METHODS: The National Electronic Injury Surveillance System-occupational supplement was used to conduct a follow-back study of workers treated in emergency departments (EDs) from June 2012 through December 2013.
RESULTS: An estimated 448,000 (95%CI 230,000-665,000) Hispanic workers treated in EDs for a work-related injury or illness were represented by 362 completed interviews. Of these, an estimated 443,000 (95%CI 228,000-657,000) workers reported the injury or illness to their employer or were self-employed. The majority had not heard of workers' compensation. Only 10% expected workers' compensation to cover their medical payment while 62% expected payment to be covered by their employer.
CONCLUSION: We characterized our respondent workforce who reported their injury or illness. We determined that NEISS-Work data are not the most appropriate source to capture underreporting of work-related injuries and illnesses to employers among Hispanic workers. Am. J. Ind. Med. 59:621-629, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Hispanic workers; foreign-born workers; injury and illness reporting; work-related injury

Mesh:

Year:  2016        PMID: 27400441     DOI: 10.1002/ajim.22606

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  1 in total

1.  Circular saw misuse is related to upper limb injuries: a cross-sectional study.

Authors:  Rodrigo Guerra Sabongi; Jaime Piccaro Erazo; Vinicius Ynoe de Moraes; Carlos Henrique Fernandes; João Baptista Gomes Dos Santos; Flávio Faloppa; João Carlos Belloti
Journal:  Clinics (Sao Paulo)       Date:  2019-09-09       Impact factor: 2.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.